Clinical characteristics and outcomes of primary antibody deficiency: A 20-year follow-up study

Journal of the Formosan Medical Association

Volumn 113, Issue 6, 2014, Pages 340-348

  Chan, Hung Yi ^a,b   Yang, Yao Hsu ^a   Yu, Hsin Hui ^a   Chien, Yin Hsiu ^a   Chiang, Li Lan ^a   Chiang, Bor Luen ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b CARDINAL TIEN HOSPITAL   (Taiwan)

Author keywords

Common variable immunodeficiency diseases; Hyper IgM syndrome; Primary antibody deficiency; Taiwan; X linked agammaglobulinemia

Indexed keywords

IMMUNOGLOBULIN G;

ADULT; ARTICLE; BRONCHIECTASIS; CLINICAL ARTICLE; COMMON VARIABLE IMMUNODEFICIENCY; FEMALE; FOLLOW UP; HUMAN; HUMORAL IMMUNE DEFICIENCY; HYPER IGM SYNDROME; IMMUNE DEFICIENCY; IMMUNOGLOBULIN DEFICIENCY; MALE; MIDDLE AGED; MOLECULAR DIAGNOSIS; PHENOTYPE; RESPIRATORY TRACT INFECTION; SKIN INFECTION; SUBSTITUTION THERAPY; TAIWAN; X LINKED AGAMMAGLOBULINEMIA; ADOLESCENT; CHILD; GENETICS; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFANT;

ADOLESCENT; CHILD; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFANT; MALE;

EID: 84899921944     PISSN: 09296646     EISSN: 18760821     Source Type: Journal    
DOI: 10.1016/j.jfma.2012.07.005     Document Type: Article

References (43)

1. De Vries E. Patient-centred screening for primary immunodeficiency: a multi-stage diagnostic protocol designed for non-immunologists. Clin Exp Immunol 2006, 145:204-214.
2. Stiehm E.R., Ochs H.D., Winkelstein J.A. Immunodeficiency disorders: general consideration. Immunologic disorders in infants and children 2004, 289-355. Saunders, Philadelphia. 5th ed. E.R. Stiehm (Ed.).
3. Benjasupattananan P., Simasathein T., Vichyanond P., Leungwedchakarn V., Visitsunthorn N., Pacharn P., et al. Clinical characteristics and outcomes of primary immunodeficiencies in Thai children: an 18-year experience from a tertiary care center. J Clin Immunol 2009, 29:357-364.
4. Javier F.C., Moore C.M., Sorensen R.U. Distribution of primary immunodeficiency diseases diagnosed in a pediatric tertiary hospital. Ann Allergy Asthma Immunol 2000, 84:25-30.
5. Onigbanjo M.T., Orange J.S., Perez E.E., Sullivan K.E. Hypogammaglobulinemia in a pediatric tertiary care setting. Clin Immunol 2007, 125:52-59.
6. Yel L. Selective IgA deficiency. J Clin Immunol 2010, 30:10-16.
7. Cunningham-Rundles C. Physiology of IgA and IgA deficiency. J Clin Immunol 2001, 21:303-309.
8. Feng M.L., Zhao Y.L., Shen T., Huang H., Yin B., Liu R.Z., et al. Prevalence of immunoglobulin A deficiency in Chinese blood donors and evaluation of anaphylactic transfusion reaction risk. Transfus Med 2011, 21:338-343.
9. Lee W.-I., Jaing T.-H., Hsieh M.-Y., Kuo M.-L., Lin S.-J., Huang J.-L. Distribution, infections, treatments and molecular analysis in a large cohort of patients with primary immunodeficiency diseases (PIDs) in Taiwan. J Clin Immunol 2006, 26:274-283.
10. Roifman C.M., Gelfand E.W. Replacement therapy with high dose intravenous gamma-globulin improves chronic sinopulmonary disease in patients with hypogammaglobulinemia. Pediatr Infect Dis J 1988, 7(5 Suppl.):S92-S96.
11. Buckley R.H., Schiff R.I. The use of intravenous immune globulin in immunodeficiency diseases. N Engl J Med 1991, 325:110-117.
12. Liese J.G., Wintergerst U., Tympner K.D., Belohradsky B.H. High- vs low-dose immunoglobulin therapy in the long-term treatment of X-linked agammaglobulinemia. Am J Dis Child 1992, 146:335-339.
13. Quartier P., Debre M., De Blic J., de Sauverzac R., Sayegh N., Jabado N., et al. Early and prolonged intravenous immunoglobulin replacement therapy in childhood agammaglobulinemia: a retrospective survey of 31 patients. J Pediatr 1999, 134:589-596.
14. Primary immunodeficiency diseases Report of a WHO scientific group. Clin Exp Immunol 1997, 109(Suppl. 1):1-28.
15. Conley M.E., Notarangelo L.D., Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol 1999, 93:190-197.
16. Lee W.I., Kuo M.L., Huang J.L., Lin S.J., Wu C.J. Distribution and clinical aspects of primary immunodeficiencies in a Taiwan pediatric tertiary hospital during a 20-year period. J Clin Immunol 2005, 25:162-173.
17. Stray-Pedersen A., Abrahamsen T.G., Froland S.S. Primary immunodeficiency diseases in Norway. J Clin Immunol 2000, 20:477-485.
18. Lim D.L., Thong B.Y., Ho S.Y., Shek L.P., Lou J., Leong K.P., et al. Primary immunodeficiency diseases in Singapore-the last 11 years. Singapore Med J 2003, 44:579-586.
19. Abuzakouk M., Feighery C. Primary immunodeficiency disorders in the Republic of Ireland: first report of the national registry in children and adults. J Clin Immunol 2005, 25:73-77.
20. Lee P.P., Lau Y.L. Primary immunodeficiencies: "new" disease in an old country. Cell Mol Immunol 2009, 6:397-406.
21. Baumgart K.W., Britton W.J., Kemp A., French M., Roberton D. The spectrum of primary immunodeficiency disorders in Australia. J Allergy Clin Immunol 1997, 100:415-423.
22. Morwood K., Bourne H., Gold M., Gillis D., Benson E.M. Phenotypic variability: clinical presentation between the 6th year and the 60th year in a family with X-linked agammaglobulinemia. J Allergy Clin Immunol 2004, 113:783-785.
23. Bykowsky M.J., Haire R.N., Ohta Y., Tang H., Sung S.S., Veksler E.S., et al. Discordant phenotype in siblings with X-linked agammaglobulinemia. Am J Hum Genet 1996, 58:477-483.
24. Lee P.P., Chen T.X., Jiang L.P., Chan K.W., Yang W., Lee B.W., et al. Clinical characteristics and genotype-phenotype correlation in 62 patients with X-linked agammaglobulinemia. J Clin Immunol 2010, 30:121-131.
25. Graziani S., Di Matteo G., Benini L., Di Cesare S., Chiriaco M., Chini L., et al. Identification of a Btk mutation in a dysgammaglobulinemic patient with reduced B cells: XLA diagnosis or not?. Clin Immunol 2008, 128:322-328.
26. Conley M.E., Farmer D.M., Dobbs A.K., Howard V., Aiba Y., Shurtleff S.A., et al. A minimally hypomorphic mutation in Btk resulting in reduced B cell numbers but no clinical disease. Clin Exp Immunol 2008, 152:39-44.
27. Plebani A. Clinical, immunological, and molecular analysis in a large cohort of patients with X-linked agammaglobulinemia: an Italian multicenter study. Clin Immunol 2002, 104:221-230.
28. Broides A., Yang W., Conley M. Genotype/phenotype correlations in X-linked agammaglobulinemia. Clin Immunol 2006, 118:195-200.
29. Chang S.H., Yang Y.H., Chiang B.L. Infectious pathogens in pediatric patients with primary immunodeficiencies. J Microbiol Immunol Infect 2006, 39:503-515.
30. Lauderdale T.L., Chang F.Y., Ben R.J., Yin H.C., Ni Y.H., Tsai J.W., et al. Etiology of community acquired pneumonia among adult patients requiring hospitalization in Taiwan. Respir Med 2005, 99:1079-1086.
31. Yen M.Y., Hu B.S., Chen Y.S., Lee S.S., Lin Y.S., Wann S.R., et al. A prospective etiologic study of community-acquired pneumonia in Taiwan. J Formos Med Assoc 2005, 104:724-730.
32. Oksenhendler E., Gerard L., Fieschi C., Malphettes M., Mouillot G., Jaussaud R., et al. Infections in 252 patients with common variable immunodeficiency. Clin Infect Dis 2008, 46:1547-1554.
33. Kainulainen L., Vuorinen T., Rantakokko-Jalava K., Österback R., Ruuskanen O. Recurrent and persistent respiratory tract viral infections in patients with primary hypogammaglobulinemia. J Allergy Clin Immunol 2010, 126:120-126.
34. Rezaei N., Aghamohammadi A., Moin M., Pourpak Z., Movahedi M., Gharagozlou M., et al. Frequency and clinical manifestations of patients with primary immunodeficiency disorders in Iran: update from the Iranian Primary Immunodeficiency Registry. J Clin Immunol 2006, 26:519-532.
35. Champi C. Primary immunodeficiency disorders in children: prompt diagnosis can lead to lifesaving treatment. J Pediatr Health Care 2002, 16:16-21.
36. Quinti I., Soresina A., Guerra A., Rondelli R., Spadaro G., Agostini C., et al. Effectiveness of immunoglobulin replacement therapy on clinical outcome in patients with primary antibody deficiencies: results from a multicenter prospective cohort study. J Clin Immunol 2011, 31:315-322.
37. Kidon M.I., Handzel Z.T., Schwartz R., Altboum I., Stein M., Zan-Bar I. Symptomatic hypogammaglobulinemia in infancy and childhood-clinical outcome and in vitro immune responses. BMC Fam Pract 2004, 5:23. Published online 2004 October 21. doi:10.1186/1471-2296-5-23.
38. Bayrakci B., Ersoy F., Sanal O., Kilic S., Metin A., Tezcan I. The efficacy of immunoglobulin replacement therapy in the long-term follow-up of the B-cell deficiencies (XLA, HIM, CVID). Turk J Pediatr 2005, 47:239-246.
39. Orange J.S., Grossman W.J., Navickis R.J., Wilkes M.M. Impact of trough IgG on pneumonia incidence in primary immunodeficiency: a meta-analysis of clinical studies. Clin Immunol 2010, 137:21-30.
40. Pourpak Z., Aghamohammadi A., Sedighipour L., Farhoudi A., Movahedi M., Gharagozlou M., et al. Effect of regular intravenous immunoglobulin therapy on prevention of pneumonia in patients with common variable immunodeficiency. J Microbiol Immunol Infect 2006, 39:114-120.
41. Eijkhout H.W., van Der Meer J.W., Kallenberg C.G., Weening R.S., van Dissel J.T., Sanders L.A., et al. The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. A randomized, double-blind, multicenter crossover trial. Ann Intern Med 2001, 135:165-174.
42. Furst D.E. Serum immunoglobulins and risk of infection: how low can you go?. Semin Arthritis Rheum 2009, 39:18-29.
43. Ballow M., Notarangelo L., Grimbacher B., Cunningham-Rundles C., Stein M., Helbert M., et al. Immunodeficiencies. Clin Exp Immunol 2009, 158:14-22.